- Home
- ATHA vs VSEE Comparison
ATHA vs VSEE Comparison
Compare ATHA & VSEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- VSEE
- Stock Information
- Founded
- ATHA 2011
- VSEE 2008
- Country
- ATHA United States
- VSEE United States
- Employees
- ATHA N/A
- VSEE N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- VSEE
- Sector
- ATHA Health Care
- VSEE
- Exchange
- ATHA Nasdaq
- VSEE NYSE
- Market Cap
- ATHA 22.3M
- VSEE 25.1M
- IPO Year
- ATHA 2020
- VSEE N/A
- Fundamental
- Price
- ATHA $0.54
- VSEE $1.38
- Analyst Decision
- ATHA Buy
- VSEE
- Analyst Count
- ATHA 4
- VSEE 0
- Target Price
- ATHA $11.25
- VSEE N/A
- AVG Volume (30 Days)
- ATHA 325.4K
- VSEE 5.9M
- Earning Date
- ATHA 11-07-2024
- VSEE 02-15-2025
- Dividend Yield
- ATHA N/A
- VSEE N/A
- EPS Growth
- ATHA N/A
- VSEE N/A
- EPS
- ATHA N/A
- VSEE N/A
- Revenue
- ATHA N/A
- VSEE $8,064,925.00
- Revenue This Year
- ATHA N/A
- VSEE N/A
- Revenue Next Year
- ATHA N/A
- VSEE N/A
- P/E Ratio
- ATHA N/A
- VSEE N/A
- Revenue Growth
- ATHA N/A
- VSEE 37.45
- 52 Week Low
- ATHA $0.41
- VSEE $1.12
- 52 Week High
- ATHA $4.30
- VSEE $33.08
- Technical
- Relative Strength Index (RSI)
- ATHA 36.91
- VSEE N/A
- Support Level
- ATHA $0.56
- VSEE N/A
- Resistance Level
- ATHA $0.61
- VSEE N/A
- Average True Range (ATR)
- ATHA 0.04
- VSEE 0.00
- MACD
- ATHA -0.01
- VSEE 0.00
- Stochastic Oscillator
- ATHA 8.45
- VSEE 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About VSEE VSEE HEALTH INC
VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.